C94.80 Código faturável e específico Other specified leukemias not having achieved remission

ICD-10-CM C94.80 identifies “Other specified leukemias not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 2: Neoplasms

Instruções do código

Inclusion terms2
  • Other specified leukemia with failed remission
  • Other specified leukemias NOS

Instruções dos níveis superiores

Capítulos 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C94 · Other leukemias of specified cell type

Excludes 14
  • leukemic reticuloendotheliosis (C91.4-)
  • myelodysplastic syndromes (D46.-)
  • personal history of leukemia (Z85.6)
  • plasma cell leukemia (C90.1-)

C94.8 · Other specified leukemias

Inclusion terms2
  • Aggressive NK-cell leukemia
  • Acute basophilic leukemia
Code also1

, if applicable, eosinophilia (D72.18)

Referências do índice oficial
Histórico

Histórico do código

Última alteração registrada · FY2024

AlteradoSem alteração
FY2024

Válido a partir de

  • Instruções herdadas alteradas

Other specified leukemias not having achieved remission

Código de diagnóstico faturável

CDC/NCHS · FY2024

Todas as edições (19)

Todas as ediçõesVálido a partir deHistórico do código
FY20162015-10-01Primeiro registro
FY20172016-10-01Sem alteração tabular
FY20182017-10-01Sem alteração tabular
FY20192018-10-01Sem alteração tabular
FY20202019-10-01Sem alteração tabular
FY2020 · April2020-04-01Sem alteração tabular
FY20212020-10-01Sem alteração tabular
FY2021 · 01-012021-01-01Sem alteração tabular
FY20222021-10-01Sem alteração tabular
FY2022 · 04-012022-04-01Sem alteração tabular
FY20232022-10-01Sem alteração tabular
FY2023 · 04-012023-04-01Sem alteração tabular
FY20242023-10-01Instruções herdadas alteradas
FY2024 · 04-012024-04-01Sem alteração tabular
FY20252024-10-01Sem alteração tabular
FY2025 · 04-012025-04-01Sem alteração tabular
FY20262025-10-01Sem alteração tabular
FY2026 · April2026-04-01Sem alteração tabular
FY20272026-10-01Sem alteração tabular
Correspondências históricas ICD-9 · 2018

Correspondência histórica; não substitui códigos automaticamente.

  • 207.80 · Aproximada

Esta entrada é um código completo na edição selecionada. A verificação da referência não estabelece adequação clínica nem garante reembolso.